Find Faculty Members at MUSC.

Sharon D. Yeatts Ph.D.

Provider Image
  • Associate Professor
  • College of Medicine
  • Public Health Sciences
Academic Focus
  • Design, conduct and analysis of clinical trials
  • Neurological emergencies, including ischemic stroke, ICH, traumatic brain injury
  • Experimental design and statistical methods for assessing dose response
Faculty email addresses should not be used to seek medical advice or to make medical appointments. Please visit MyChart for medical appointments or to contact your provider.


Office Location


Dr. Yeatts is an Associate Professor of Biostatistics in the Department of Public Health Sciences at the Medical University of South Carolina.  She is also a faculty member with the  Data Coordination Unit (DCU), an  NIH-funded statistical and data coordinating center that specializes in the design and coordination of multicenter clinical trials.  Dr. Yeatts has a strong background in biostatistics, with specific training and experience in the planning, implementation and analysis of Phase I-III clinical trials. 

As the PI of the Statistics and Data Management Center for the phase I and II trials of deferoxamine in ICH, Dr. Yeatts is responsible for the design of the trial and the implementation of the statistical and data/project management workscope.  Dr. Yeatts is the PI of the National Data Management Center for DEFUSE 3, a multicenter clinical trial using an adaptive design to assess the efficacy of endovascular therapy following imaging evaluation in ischemic stroke.  In addition, Dr. Yeatts was the primary unblinded statistician for the large Phase III trials of the Interventional Management of Stroke (IMS-III) and progesterone in traumatic brain injury (ProTECT).  As a co-investigator on these grants, she was responsible for the statistical monitoring of data and the implementation of interim and final efficacy and safety analyses. 

Dr. Yeatts serves on Data and Safety Monitoring Boards and as a grant reviewer for several funding agencies.  Her primary research interests include the development and implementation of efficient early phase trial designs and novel trial outcomes.